Analysts foresee more revenue Amgen

Next Monday the American Amgen will report its past quarters results. Over the current book year the total revenu from the company based in Thousand Oaks will be 26.18 billion USD (consensus estimates). This is slightly more than 2021's revenue of 25.98 billion USD.

Historical revenues and results Amgen plus estimates 2021

The analysts expect for 2021 a net profit of 9.65 billion USD. The majority of the analysts expects for this year a profit per share of 17.64 USD. The PE-ratio therefore is 14.48.

Analysts expect a dividend of 7.62 USD per share. The dividend yield is then 2.98 percent. The average dividend yield of the biotech companies equals an attractive 2.64 percent.

Based on the current number of outstanding shares Amgen 's market capitalization 147.73 billion USD. 3

Historical stock prices Amgen

ValueSpectrum.com News Wire & Equity Research: +31 084-0032-842
news@valuespectrum.com

Copyright analist.nl B.V.
All rights reserved. Any redistribution, duplication or archiving prohibited. analist.nl doesn't warrant the accuracy of any News Content provided and shall not be liable for any errors, inaccuracies or for any actions taken in reliance thereon.